GO
Loading...

What Cramer expects from IPO market

Monday, 12 May 2014 | 9:08 AM ET

Allergan has rejected a $47 billion takeover bid by Valeant Pharmaceuticals. The "Squawk on the Street" news team discuss m&a in pharmaceuticals and the IPO market.